Autosomal Dominant Hypocalcemia
1 clinical trials · Condition
◉ Watch Autosomal Dominant Hypocalcemia
| Record | Firm | Date |
|---|---|---|
| ADH1 and ADH2 Disease Monitoring Study (DMS) (NCT05227287) | Calcilytix Therapeutics, Inc., a BridgeBio company | 2022-01-20 |
Track Autosomal Dominant Hypocalcemia automatically
Every clearance here is in the API, with alerts when new ones post.